News

Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...
Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The ...
Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network ...
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...